{
    "clinical_study": {
        "@rank": "84153", 
        "arm_group": [
            {
                "arm_group_label": "Cohort A: ddAC -> T+PH", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Cohort B: FEC -> D+PH", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This multicenter, non-randomized, open-label, phase II study is designed to evaluate the\n      safety and efficacy of Perjeta in combination with Herceptin and anthracycline-based\n      chemotherapy as neoadjuvant treatment in patients with HER2-based locally advanced,\n      inflammatory, or early-stage breast cancer. Each investigator will choose a treatment\n      regimen (A or B) for all their patients to follow. Treatment A (Cohort A): Patients will\n      first be given doxorubicin (60 mg/m2 IV) and cyclophosphamide (600 mg/m2 IV). This will be\n      followed by administration of paclitaxel (80 mg/m2 IV), Perjeta (420 mg IV) and Herceptin (6\n      mg IV) for four cycles. Treatment B (Cohort B): Patients will first receive 5-fluorouracil\n      (500 mg/m2 IV), epirubicin (100 mg/m2 IV), and cyclophosphamide (600 mg/m2 IV). This is to\n      be followed by docetaxel (100 mg/m2 IV), Perjeta (420 mg IV) and Herceptin (6 mg IV)\n      treatment for four cycles. Patients in both cohorts will subsequently undergo surgical t!\n      reatment and then resume Perjeta and Herceptin treatment. Total time on treatment is\n      expected to last 1 year; patients will be followed-up for a further 4 years."
        }, 
        "brief_title": "A Study Evaluating Perjeta (Pertuzumab) Combined With Herceptin (Trastuzumab) and Standard Anthracycline-based Chemotherapy in Patients With HER2-positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer.", 
        "completion_date": {
            "#text": "March 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age >/= 18 years\n\n          -  Male and female patients with locally advanced, inflammatory, or early-stage,\n             unilateral, and histologically confirmed invasive breast cancer.  Patients with\n             inflammatory breast cancer must be able to have a core needle biopsy.\n\n          -  Primary tumor > 2 cm in diameter, or > 5 mm in diameter and node-positive\n\n          -  HER2-positive breast cancer confirmed by a central laboratory\n\n          -  Availability of tumor tissue specimen\n\n          -  Baseline left ventricular ejection fraction (LVEF) >/= 55%\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status </= 1\n\n          -  At least 4 weeks since major unrelated surgery, with full recovery\n\n          -  Use of effective contraception as defined by the protocol. Contraception must be used\n             until at least 7 months after the last dose of study treatment.\n\n        Exclusion Criteria:\n\n          -  Metastatic disease (Stage IV) or bilateral breast cancer\n\n          -  Patients who have had an incisional biopsy of the primary tumor or the primary tumor\n             excised\n\n          -  History of other malignancies within 5 years prior to study entry, except for\n             carcinoma in situ of the cervix, carcinoma in situ of the colon, melanoma in situ,\n             and basal cell and squamous cell carcinoma of the skin.  Patients with malignancies\n             occurring more than 5 years prior to study entry are permitted if curatively treated\n             with surgery alone.\n\n          -  Any previous systemic therapy (including chemotherapy, immunotherapy, HER2 targeted\n             agents, and antitumor vaccines) for cancer, or radiation therapy for cancer\n\n          -  Patients with a past history of ductal carcinoma in situ (DCIS) or lobular carcinoma\n             in situ (LCIS) are not allowed to enter the study if they have received any systemic\n             therapy for its treatment or radiation therapy to the ipsilateral breast (they are\n             allowed to enter the study if treated with surgery alone).\n\n          -  High-risk patients who have received chemopreventative drugs in the past are not\n             allowed to enter the study.\n\n          -  Inadequate bone marrow, renal, or liver function.\n\n          -  History or evidence of cardiovascular condition.\n\n          -  Any other concomitant serious medical condition, including infection with HIV,\n             hepatitis B virus, or hepatitis C virus.\n\n          -  Pregnancy or breast-feeding.\n\n          -  Patients who received any investigational treatment within 4 weeks of study start\n\n          -  Current chronic daily treatment with corticosteroids (dose > 10 mg methylprednisolone\n             or equivalent [excluding inhaled steroids])."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02132949", 
            "org_study_id": "WO29217"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cohort A: ddAC -> T+PH", 
                "description": "60 mg/m2 IV given every 2 weeks for 8 weeks (Cycles 1-4)", 
                "intervention_name": "doxorubicin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort A: ddAC -> T+PH", 
                "description": "600 mg/m2 IV given every 2 weeks for 8 weeks (Cycles 1-4)", 
                "intervention_name": "cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort A: ddAC -> T+PH", 
                "description": "80 mg/m2 IV given weekly for 12 weeks (Cycles 5-8)", 
                "intervention_name": "paclitaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort B: FEC -> D+PH", 
                "description": "500 mg/m2 IV given every 3 weeks for 12 weeks (Cycles 1-4)", 
                "intervention_name": "5-fluorouracil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort B: FEC -> D+PH", 
                "description": "100 mg/m2 IV given every 3 weeks for 12 weeks (Cycles 1-4)", 
                "intervention_name": "epirubicin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort B: FEC -> D+PH", 
                "description": "600 mg/m2 IV given every 3 weeks for 12 weeks (Cycles 1-4)", 
                "intervention_name": "cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort B: FEC -> D+PH", 
                "description": "100 mg/m2 (75 mg/m2 first dose) IV given every 3 weeks for 12 weeks (Cyles 5-8)", 
                "intervention_name": "docetaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Cohort A: ddAC -> T+PH", 
                    "Cohort B: FEC -> D+PH"
                ], 
                "description": "6 mg/kg (8 mg/kg first dose) IV given every 3 weeks for 17 cycles", 
                "intervention_name": "trastuzumab [Herceptin]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Cohort A: ddAC -> T+PH", 
                    "Cohort B: FEC -> D+PH"
                ], 
                "description": "420 mg (840 mg first dose) IV given every 3 weeks for 17 cycles", 
                "intervention_name": "pertuzumab [Perjeta]", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Fluorouracil", 
                "Docetaxel", 
                "Trastuzumab", 
                "Doxorubicin", 
                "Epirubicin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Greenbrae", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94904"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90025"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06105"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Weston", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33331"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marietta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30060"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsfield", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01201"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kalispell", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59901"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07601"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morristown", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07960"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "New Mexico", 
                        "zip": "87401"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Setauket", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11733"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middletown", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45042"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hershey", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "17033"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amarillo", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79106"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84112"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53705"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barrie", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L4M 6M2"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Laval", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H7M 3L9"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H3T 1M5"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H4J 1C5"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regina", 
                        "country": "Canada", 
                        "state": "Saskatchewan", 
                        "zip": "S4T 7T1"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "01307"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "G\u00f6ttingen", 
                        "country": "Germany", 
                        "zip": "37073"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Langen", 
                        "country": "Germany", 
                        "zip": "63225"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "81675"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Neuruppin", 
                        "country": "Germany", 
                        "zip": "16816"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland", 
                        "zip": "15-027"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland", 
                        "zip": "31-531"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20-090"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Otwock", 
                        "country": "Poland", 
                        "zip": "05-400"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poznan", 
                        "country": "Poland", 
                        "zip": "61-866"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisboa", 
                        "country": "Portugal", 
                        "zip": "1649-035"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisboa", 
                        "country": "Portugal", 
                        "zip": "1400-038"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Loures", 
                        "country": "Portugal", 
                        "zip": "2674-514"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto", 
                        "country": "Portugal", 
                        "zip": "4200-072"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08916"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Coruna", 
                        "country": "Spain", 
                        "state": "La Coru\u00f1a", 
                        "zip": "15009"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28002"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41009"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "Spain", 
                        "zip": "45004"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom", 
                        "zip": "BA1 3NG"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bournemouth", 
                        "country": "United Kingdom", 
                        "zip": "BH7 7DW"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "zip": "G12 0YN"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guildford", 
                        "country": "United Kingdom", 
                        "zip": "GU2 7XX"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SE1 9RT"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6JJ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Castle upon Tyne", 
                        "country": "United Kingdom", 
                        "zip": "NE7 7DN"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Northwood", 
                        "country": "United Kingdom", 
                        "zip": "HA6 2RN"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom", 
                        "zip": "OX3 7LJ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peterborough", 
                        "country": "United Kingdom", 
                        "zip": "PE3 9GZ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sutton", 
                        "country": "United Kingdom", 
                        "zip": "SM2 5PT"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Germany", 
                "Poland", 
                "Portugal", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Multinational, Phase II Study to Evaluate Pertuzumab in Combination With Trastuzumab and Standard Neoadjuvant Anthracycline-based Chemotherapy in Patients With HER2-Positive, Locally Advanced, Inflammatory, or Early-Stage Breast Cancer", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: WO29217 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2021", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of cardiac events as assessed by the investigator using National Cancer Institute (NCI) Common Terminology for Adverse Events (CTCAE) v. 4.0", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Changes in left ventricular ejection fraction assessed by ECHO or MUGA scan.", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02132949"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Incidence of anti-therapeutic antibodies to Perjeta", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Total pathological complete response defined as the eradication of invasive disease according to pathologist assessment", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Clinical response as assessed by the investigator according to response evaluation criteria in solid tumors (RECIST) v. 1.1", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Event-free survival defined as time from enrollment to first occurrence of progressive disease, relapse, or death from any cause.", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Invasive disease-free survival defined as the time from the first date of no disease to the first documentation of progressive invasive disease, relapse, or death from any cause.", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }, 
            {
                "measure": "Overall survival, defined as the time from enrollment to death from any cause.", 
                "safety_issue": "No", 
                "time_frame": "Approximately 5 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}